AU562293B2 - Parenteral formulation of nimodipine - Google Patents

Parenteral formulation of nimodipine

Info

Publication number
AU562293B2
AU562293B2 AU27583/84A AU2758384A AU562293B2 AU 562293 B2 AU562293 B2 AU 562293B2 AU 27583/84 A AU27583/84 A AU 27583/84A AU 2758384 A AU2758384 A AU 2758384A AU 562293 B2 AU562293 B2 AU 562293B2
Authority
AU
Australia
Prior art keywords
weight
per cent
nimodipine
parenteral formulation
soivent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU27583/84A
Other languages
English (en)
Other versions
AU2758384A (en
Inventor
Dieter Hoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2758384A publication Critical patent/AU2758384A/en
Application granted granted Critical
Publication of AU562293B2 publication Critical patent/AU562293B2/en
Assigned to BAYER HEALTHCARE AG reassignment BAYER HEALTHCARE AG Alteration of Name(s) in Register under S187 Assignors: BAYER AKTIENGESELLSCHAFT
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
AU27583/84A 1983-05-06 1984-05-02 Parenteral formulation of nimodipine Expired AU562293B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833316510 DE3316510A1 (de) 1983-05-06 1983-05-06 Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
DE3316510 1983-05-06

Publications (2)

Publication Number Publication Date
AU2758384A AU2758384A (en) 1984-11-08
AU562293B2 true AU562293B2 (en) 1987-06-04

Family

ID=6198265

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27583/84A Expired AU562293B2 (en) 1983-05-06 1984-05-02 Parenteral formulation of nimodipine

Country Status (19)

Country Link
US (1) US5114956A (enExample)
EP (1) EP0126315B1 (enExample)
JP (1) JPS59206305A (enExample)
KR (1) KR920000306B1 (enExample)
AT (1) ATE24835T1 (enExample)
AU (1) AU562293B2 (enExample)
BE (1) BE899564A (enExample)
CA (1) CA1220424A (enExample)
DE (2) DE3316510A1 (enExample)
DK (1) DK164148C (enExample)
ES (1) ES8505542A1 (enExample)
FR (1) FR2545354B1 (enExample)
GR (1) GR81609B (enExample)
HK (1) HK75889A (enExample)
IL (1) IL71744A (enExample)
IT (1) IT1181804B (enExample)
PT (1) PT78542B (enExample)
SG (1) SG44489G (enExample)
ZA (1) ZA843352B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
AT387518B (de) * 1985-12-18 1989-02-10 Bayer Ag Verfahren zur herstellung von fluessigen spruehpraeparaten von dihydropyridinen
DE3702105A1 (de) * 1987-01-24 1988-08-04 Bayer Ag Parenterale loesung
GB2228412B (en) * 1989-02-28 1993-04-14 Syntex Inc Nicardipine pharmaceutical composition for parenteral administration
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
JPH10510540A (ja) 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
ES2377126T3 (es) * 1994-12-12 2012-03-22 Omeros Corporation Solución de irrigación y utilización de la misma para la inhibición perioperatoria del dolor, la inflamación y/o los espasmos en una estructura vascular
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
US8034762B2 (en) 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
WO2007047406A2 (en) * 2005-10-14 2007-04-26 Transform Pharmaceuticals, Inc. Liquid pharmaceutical compositions of nimodipine
WO2007125028A1 (de) * 2006-04-28 2007-11-08 Basf Se Verfahren zur solubilisierung von hydrophoben wirkstoffen in wässrigem medium
CN102741327B (zh) 2010-02-05 2014-11-05 巴斯夫欧洲公司 在水溶液中加溶疏水性活性成分的方法
US8728504B2 (en) 2010-02-05 2014-05-20 Basf Se Process for solubilizing hydrophobic active ingredients in aqueous medium
US9364433B2 (en) 2011-04-28 2016-06-14 Borje S. Andersson Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
PT3442586T (pt) * 2016-04-13 2022-09-28 Acasti Pharma U S Inc Formulação parentérica estável de nimodipina
US10092553B2 (en) 2016-04-13 2018-10-09 Nortic Holdings Inc. Stable nimodipine parenteral formulation
US20190255033A1 (en) 2018-02-22 2019-08-22 Nortic Holdings Inc. Stable Nimodipine Parenteral Formulation
CN119300828A (zh) 2022-05-16 2025-01-10 美国阿卡斯蒂制药股份有限公司 尼莫地平肠胃外给药

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2650013C3 (de) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
DE3316510A1 (de) 1984-11-08
SG44489G (en) 1989-11-17
ATE24835T1 (de) 1987-01-15
KR840009031A (ko) 1984-12-24
FR2545354B1 (fr) 1986-09-26
DK164148C (da) 1992-10-26
IT1181804B (it) 1987-09-30
GR81609B (enExample) 1984-12-11
ZA843352B (en) 1984-12-24
CA1220424A (en) 1987-04-14
DE3461988D1 (en) 1987-02-19
IL71744A (en) 1988-04-29
ES531995A0 (es) 1985-06-01
US5114956A (en) 1992-05-19
JPH0422888B2 (enExample) 1992-04-20
ES8505542A1 (es) 1985-06-01
FR2545354A1 (fr) 1984-11-09
HK75889A (en) 1989-09-29
KR920000306B1 (ko) 1992-01-11
EP0126315B1 (de) 1987-01-14
IT8448139A1 (it) 1985-11-04
DK224184A (da) 1984-11-07
AU2758384A (en) 1984-11-08
BE899564A (fr) 1984-11-05
IL71744A0 (en) 1984-09-30
DK164148B (da) 1992-05-18
PT78542B (en) 1986-07-14
EP0126315A1 (de) 1984-11-28
IT8448139A0 (it) 1984-05-04
PT78542A (en) 1984-06-01
DK224184D0 (da) 1984-05-04
JPS59206305A (ja) 1984-11-22

Similar Documents

Publication Publication Date Title
AU562293B2 (en) Parenteral formulation of nimodipine
IT7925174A0 (it) Copolimero elastomero isoprene-butadiene dotato di migliorate proprieta' di lavorazione.
CA2061486A1 (en) Stabilised polymers having hetero atoms in the main chain
ATE96454T1 (de) Nichtvernetzte schaumstoffzusammensetzung.
DE59705951D1 (de) Kosmetisches Mittel mit polymergebundenen Benzophenonchromophoren
EP0809622A4 (en) ANTI-INFLAMMATORY DERIVATIVES OF BENZOIC ACID
EP0477748A3 (en) Very or ultra high molecular weight polyethylene moulding compositions
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
AU557186B2 (en) Halo-substituted sucrose derivatives
IT1201481B (it) Pantotenil derivati
AU625627B2 (en) Triazinic compounds
IT1281198B1 (it) Film termoretraibili basati su composizioni poliolefiniche comprendenti un copolimero lineare dell'etilene con alfa-olefine
FR2682951B1 (enExample)
AU536270B2 (en) Cytostatic iso cyanuric compositions
EP0118565A4 (en) 1,4-METHANO-2-BENZAZEPINE DERIVATIVES.
ATE52964T1 (de) Polyaethylenmischung, daraus hergestellte filme und verpackungen.
AU4598889A (en) Liquid separating agent
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
GR74782B (enExample)
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
AU1828983A (en) Slip and block additives for olefin polymers
FI930300L (fi) 5-Amino-1,2,4-tiadiatsol-3-yyli-iminokarbonyyliyhdiste

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: BAYER HEALTHCARE AG

Free format text: FORMER OWNER WAS: BAYER A.G.